We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NBY market cap is 3.55M. The company's latest EPS is USD -3.4175 and P/E is -0.21.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.61M | 3.27M | 3.73M | 2.63M | 2.4M |
| Operating Income | -1.36M | -1.12M | -3.39M | -2.44M | -1.05M |
| Net Income | -4.03M | -1.76M | -9.17M | -3.59M | -1.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.6M | 9.93M | 8.42M | 14.4M | 14.73M |
| Operating Income | -9.4M | -6.43M | -8.86M | -14.42M | -7.6M |
| Net Income | -10.46M | -11.04M | -6.56M | -16.27M | -16.7M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.01M | 12.85M | 9.03M | 5.36M | 3.93M |
| Total Liabilities | 7.45M | 5.82M | 5.72M | 5.2M | 4.54M |
| Total Equity | 8.56M | 7.04M | 3.31M | 160k | -617k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.22M | 15.24M | 23.98M | 16.4M | 9.03M |
| Total Liabilities | 10.25M | 2.92M | 13.81M | 5.85M | 5.72M |
| Total Equity | 973k | 12.32M | 10.17M | 10.55M | 3.31M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.45M | -3.82M | -4.13M | -1.57M | -2.15M |
| Investing | -15k | -17k | -19k | 1.07M | 1.07M |
| Financing | 2.51M | 1.94M | 1.91M | -597k | -1.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.93M | -4.72M | -9.19M | -6.65M | -4.13M |
| Investing | -19k | -26k | -12.05M | -112k | -19k |
| Financing | 11.7M | 9.76M | 16.79M | 4.63M | 1.91M |
| Market Cap | 3.55M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 0.24 |
| Price to Cash Ratio | 1.14 |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 4.89M |
| Average Volume (1 week) | 184.94k |
| Average Volume (1 Month) | 1.15M |
| 52 Week Change | -93.71% |
| 52 Week High | 12.075 |
| 52 Week Low | 0.3611 |
| Spread (Intraday) | 0.12 (16.27%) |
| Company Name | NovaBay Pharmaceuticals Inc New |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novabay.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
